Please enable JavaScript to continue using this application.

Compare $CRDF vs $PDSB | Chartloom

Compare

$CRDF vs $PDSB

Cardiff Oncology Inc · PDS Biotechnology Corp

CRDF

Cardiff Oncology Inc

PDSB

PDS Biotechnology Corp

Compare $CRDF vs $PDSB

Comparing Cardiff Oncology Inc and PDS Biotechnology Corp

CRDFCardiff Oncology Inc

PDSBPDS Biotechnology Corp

CRDFCardiff Oncology Inc

Market cap

$84M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

244.08x

Rev growth (TTM)

-7.0%

YTD performance

-59.4%

52W performance

-54.6%

FCF yield

-48.7%

PDSBPDS Biotechnology Corp

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

65.6%

52W performance

38.0%

FCF yield

-21.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRDF

PDSB

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

PDSB

PDS Biotechnology Corp

Market Cap

CRDF$84M

PDSB$77M

Enterprise Value

CRDF$75M

PDSB$76M

Price

CRDF$1.08

PDSB$1.38

P/E Ratio

CRDFN/A

PDSBN/A

P/S Ratio

CRDF165.40x

PDSB0.00x

EV/Sales

CRDF147.30x

PDSB0.00x

EV/EBITDA

CRDF0.00x

PDSB0.00x

P/B Ratio

CRDF3.28x

PDSB10.76x

P/FCF Ratio

CRDFN/A

PDSBN/A

EV/FCF

CRDF-1.83x

PDSB-4.52x

PEG Ratio

CRDFN/A

PDSBN/A

Forward P/E (NTM)

CRDFN/A

PDSBN/A

Forward P/S (NTM)

CRDF244.08x

PDSBN/A

Revenue (TTM)

CRDF$508K

PDSB$0

Revenue Growth (YoY)

CRDF-7.0%

PDSBN/A

Forward Rev Growth

CRDF-19.6%

PDSB4816.2%

Gross Margin (TTM)

CRDF100.0%

PDSB0.0%

Operating Margin (TTM)

CRDF0.0%

PDSB0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

PDSB0.0%

Net Margin (TTM)

CRDF-7889.0%

PDSB0.0%

FCF Margin (TTM)

CRDF-8054.3%

PDSBN/A

Net Income (TTM)

CRDF$-40M

PDSB$-34M

FCF (TTM)

CRDF$-41M

PDSB$-17M

EPS (TTM)

CRDF-$0.59

PDSB-$0.60

ROE (TTM)

CRDF-10308.0%

PDSB-34603.0%

ROA (TTM)

CRDF-7551.0%

PDSB-13650.0%

ROIC (TTM)

CRDF-10308.0%

PDSB-12371.0%

Cash

CRDF$9M

PDSB$6M

Debt

CRDF$0

PDSB$4M

Net Cash/Debt

CRDF$9M

PDSB$1M

Current Ratio (TTM)

CRDF3.30x

PDSB0.57x

Quick Ratio (TTM)

CRDF3.21x

PDSB0.45x

Debt/Equity (TTM)

CRDF0.00x

PDSB4.07x

Debt/Assets (TTM)

CRDF0.0%

PDSB0.0%

Interest Coverage (TTM)

CRDFN/A

PDSBN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

PDSB0.00x

Beta

CRDF1.49

PDSB1.30

52W Performance

CRDF-54.6%

PDSB38.0%

YTD Performance

CRDF-59.4%

PDSB65.6%

% from 52W High

CRDF-67.4%

PDSB-11.0%

% from 52W Low

CRDF42.7%

PDSB607.0%

Asset Turnover (TTM)

CRDF0.01x

PDSB0.00x

FCF Yield (TTM)

CRDF-48.7%

PDSB-21.7%

Earnings Yield (TTM)

CRDF-47.7%

PDSB-43.6%

Dividend Yield (TTM)

CRDFN/A

PDSBN/A

Rule of 40

CRDF-8,061.3

PDSB0.0

EV/GP/RG

CRDFN/A

PDSBN/A

Ticker research

View CRDF research View PDSB research

Metric	CRDF Cardiff Oncology Inc	PDSB PDS Biotechnology Corp
Market & Valuation
Market Cap	$84M	$77M
Enterprise Value	$75M	$76M
Price	$1.08	$1.38
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	0.00x
EV/Sales	147.30x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	10.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-4.52x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	N/A
Revenue & Growth
Revenue (TTM)	$508K	$0
Revenue Growth (YoY)	-7.0%	N/A
Forward Rev Growth	-19.6%	4816.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	0.0%
Net Margin (TTM)	-7889.0%	0.0%
FCF Margin (TTM)	-8054.3%	N/A
Net Income (TTM)	$-40M	$-34M
FCF (TTM)	$-41M	$-17M
EPS (TTM)	-$0.59	-$0.60
ROE (TTM)	-10308.0%	-34603.0%
ROA (TTM)	-7551.0%	-13650.0%
ROIC (TTM)	-10308.0%	-12371.0%
Financial Health
Cash	$9M	$6M
Debt	$0	$4M
Net Cash/Debt	$9M	$1M
Current Ratio (TTM)	3.30x	0.57x
Quick Ratio (TTM)	3.21x	0.45x
Debt/Equity (TTM)	0.00x	4.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	1.30
52W Performance	-54.6%	38.0%
YTD Performance	-59.4%	65.6%
% from 52W High	-67.4%	-11.0%
% from 52W Low	42.7%	607.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-48.7%	-21.7%
Earnings Yield (TTM)	-47.7%	-43.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View PDSB research

Valuation

P/S Ratio

PDSB

0.00x

CRDF

165.40x

EV/FCF

PDSB

-4.52x

CRDF

-1.83x

Growth & revenue

Revenue Growth TTM

CRDF

-7.0%

Forward Revenue Growth

PDSB

4816.2%

CRDF

-19.6%

Profitability & performance

Gross Margin

CRDF

100.0%

PDSB

0.0%

ROE

CRDF

-10308.0%

PDSB

-34603.0%

FCF Yield %

PDSB

-21.7%

CRDF

-48.7%

52-Week Performance

PDSB

38.0%

CRDF

-54.6%

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

PDSB

PDS Biotechnology Corp

Market Cap

CRDF$84M

PDSB$77M

Enterprise Value

CRDF$75M

PDSB$76M

Price

CRDF$1.08

PDSB$1.38

P/E Ratio

CRDFN/A

PDSBN/A

P/S Ratio

CRDF165.40x

PDSB0.00x

EV/Sales

CRDF147.30x

PDSB0.00x

EV/EBITDA

CRDF0.00x

PDSB0.00x

P/B Ratio

CRDF3.28x

PDSB10.76x

P/FCF Ratio

CRDFN/A

PDSBN/A

EV/FCF

CRDF-1.83x

PDSB-4.52x

PEG Ratio

CRDFN/A

PDSBN/A

Forward P/E (NTM)

CRDFN/A

PDSBN/A

Forward P/S (NTM)

CRDF244.08x

PDSBN/A

Revenue (TTM)

CRDF$508K

PDSB$0

Revenue Growth (YoY)

CRDF-7.0%

PDSBN/A

Forward Rev Growth

CRDF-19.6%

PDSB4816.2%

Gross Margin (TTM)

CRDF100.0%

PDSB0.0%

Operating Margin (TTM)

CRDF0.0%

PDSB0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

PDSB0.0%

Net Margin (TTM)

CRDF-7889.0%

PDSB0.0%

FCF Margin (TTM)

CRDF-8054.3%

PDSBN/A

Net Income (TTM)

CRDF$-40M

PDSB$-34M

FCF (TTM)

CRDF$-41M

PDSB$-17M

EPS (TTM)

CRDF-$0.59

PDSB-$0.60

ROE (TTM)

CRDF-10308.0%

PDSB-34603.0%

ROA (TTM)

CRDF-7551.0%

PDSB-13650.0%

ROIC (TTM)

CRDF-10308.0%

PDSB-12371.0%

Cash

CRDF$9M

PDSB$6M

Debt

CRDF$0

PDSB$4M

Net Cash/Debt

CRDF$9M

PDSB$1M

Current Ratio (TTM)

CRDF3.30x

PDSB0.57x

Quick Ratio (TTM)

CRDF3.21x

PDSB0.45x

Debt/Equity (TTM)

CRDF0.00x

PDSB4.07x

Debt/Assets (TTM)

CRDF0.0%

PDSB0.0%

Interest Coverage (TTM)

CRDFN/A

PDSBN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

PDSB0.00x

Beta

CRDF1.49

PDSB1.30

52W Performance

CRDF-54.6%

PDSB38.0%

YTD Performance

CRDF-59.4%

PDSB65.6%

% from 52W High

CRDF-67.4%

PDSB-11.0%

% from 52W Low

CRDF42.7%

PDSB607.0%

Asset Turnover (TTM)

CRDF0.01x

PDSB0.00x

FCF Yield (TTM)

CRDF-48.7%

PDSB-21.7%

Earnings Yield (TTM)

CRDF-47.7%

PDSB-43.6%

Dividend Yield (TTM)

CRDFN/A

PDSBN/A

Rule of 40

CRDF-8,061.3

PDSB0.0

EV/GP/RG

CRDFN/A

PDSBN/A

Ticker research

View CRDF research View PDSB research

Metric	CRDF Cardiff Oncology Inc	PDSB PDS Biotechnology Corp
Market & Valuation
Market Cap	$84M	$77M
Enterprise Value	$75M	$76M
Price	$1.08	$1.38
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	0.00x
EV/Sales	147.30x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	10.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-4.52x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	N/A
Revenue & Growth
Revenue (TTM)	$508K	$0
Revenue Growth (YoY)	-7.0%	N/A
Forward Rev Growth	-19.6%	4816.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	0.0%
Net Margin (TTM)	-7889.0%	0.0%
FCF Margin (TTM)	-8054.3%	N/A
Net Income (TTM)	$-40M	$-34M
FCF (TTM)	$-41M	$-17M
EPS (TTM)	-$0.59	-$0.60
ROE (TTM)	-10308.0%	-34603.0%
ROA (TTM)	-7551.0%	-13650.0%
ROIC (TTM)	-10308.0%	-12371.0%
Financial Health
Cash	$9M	$6M
Debt	$0	$4M
Net Cash/Debt	$9M	$1M
Current Ratio (TTM)	3.30x	0.57x
Quick Ratio (TTM)	3.21x	0.45x
Debt/Equity (TTM)	0.00x	4.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	1.30
52W Performance	-54.6%	38.0%
YTD Performance	-59.4%	65.6%
% from 52W High	-67.4%	-11.0%
% from 52W Low	42.7%	607.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-48.7%	-21.7%
Earnings Yield (TTM)	-47.7%	-43.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View PDSB research